Dual Antiplatelet (DAPT) Therapy

DRUG3 trials

Sponsors

HonorHealth Research Institute, J.P.S Henriques, Second Affiliated Hospital, School of Medicine, Zhejiang University

Conditions

AtherosclerosisCoronary Arterial Disease (CAD)Coronary Artery DiseaseNo-Reflow PhenomenonPercutaneous Coronary Intervention (PCI)ST Elevation Myocardial InfarctionStent Placement

Phase 2

SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet Therapy

TerminatedNCT03606642

HonorHealth Research InstituteAtherosclerosis, Coronary Artery Disease, Stent Placement

Start: 2018-11-19End: 2022-08-08Updated: 2024-12-27

Phase 4

Prasugrel Monotherapy Reduced Dose in Acute and Chronic Coronary Syndrome Patients After Percutaneous Coronary Intervention (PROMOTE)

RecruitingNCT06916520

J.P.S HenriquesCoronary Arterial Disease (CAD), Percutaneous Coronary Intervention (PCI)

Start: 2025-11-13End: 2027-04-01Target: 300Updated: 2026-03-04

Rivaroxaban for Slow Coronary Flow After PCI in STEMI

Not yet recruitingNCT07195812

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNo-Reflow Phenomenon, ST Elevation Myocardial Infarction

Start: 2025-10-31End: 2028-05-31Target: 60Updated: 2025-09-29